An enhanced mixture method for constructing gatekeeping procedures in clinical trials

ABSTRACT It is increasingly common to encounter complex multiplicity problems with several multiplicity components in confirmatory Phase III clinical trials. These components are often based on several endpoints (primary and secondary endpoints) and several dose-control comparisons. When constructing a multiplicity adjustment in these settings, it is important to control the Type I error rate over all multiplicity components. An important class of multiple testing procedures, known as gatekeeping procedures, was derived using the mixture method that enables clinical trial sponsors to set up efficient multiplicity adjustments that account for clinically relevant logical relationships among the hypotheses of interest. An enhanced version of this mixture method is introduced in this paper to construct more powerful gatekeeping procedures for a specific type of logical relationships that rely on transitive serial restrictions. Restrictions of this kind are very common in Phase III clinical trials and the proposed method is applicable to a broad class of multiplicity problems. Several examples are provided to illustrate the new method and results of simulation trials are presented to compare the performance of gatekeeping procedures derived using this method and other available methods.

[1]  R. D'Agostino,et al.  Traditional multiplicity adjustment methods in clinical trials , 2013, Statistics in medicine.

[2]  R. D'Agostino,et al.  Key multiplicity issues in clinical drug development , 2013, Statistics in medicine.

[3]  Alex Dmitrienko,et al.  Mixtures of multiple testing procedures for gatekeeping applications in clinical trials , 2011, Statistics in medicine.

[4]  K. Gabriel,et al.  On closed testing procedures with special reference to ordered analysis of variance , 1976 .

[5]  Sue-Jane Wang,et al.  Some Controversial Multiple Testing Problems in Regulatory Applications , 2009, Journal of biopharmaceutical statistics.

[6]  Alex Dmitrienko,et al.  Clinical Scenario Evaluation and Clinical Trial Optimization , 2017 .

[7]  Alex Dmitrienko,et al.  Clinical Trial Optimization Using R , 2017 .

[8]  Mohamed Alosh,et al.  Advanced multiplicity adjustment methods in clinical trials , 2014, Statistics in medicine.

[9]  A. Tamhane,et al.  General theory of mixture procedures for gatekeeping , 2013, Biometrical journal. Biometrische Zeitschrift.

[10]  Mervyn J. Silvapulle,et al.  Beyond Parametrics in Interdisciplinary Research: Festschrift in Honor of Professor Pranab K. Sen , 2008 .

[11]  A. Dmitrienko,et al.  Tradeoff-based optimization criteria in clinical trials with multiple objectives and adaptive designs , 2016, Journal of biopharmaceutical statistics.

[12]  Alex Dmitrienko,et al.  General Multistage Gatekeeping Procedures , 2008, Biometrical journal. Biometrische Zeitschrift.

[13]  Alex Dmitrienko,et al.  Gatekeeping Procedures in Clinical Trials , 2009 .

[14]  Sanat K. Sarkar,et al.  On the Simes inequality and its generalization , 2008, 0805.2322.

[15]  A. Dmitrienko,et al.  Mixture-based gatekeeping procedures for multiplicity problems with multiple sequences of hypotheses , 2016, Journal of biopharmaceutical statistics.

[16]  Guideline on multiplicity issues in clinical trials 4 Draft 5 Draft agreed , 2017 .

[17]  Isaac Dialsingh,et al.  Multiple testing problems in pharmaceutical statistics , 2011 .

[18]  Alex Dmitrienko,et al.  Development of gatekeeping strategies in confirmatory clinical trials , 2011, Biometrical journal. Biometrische Zeitschrift.

[19]  Alex Dmitrienko,et al.  A Mixture Gatekeeping Procedure Based on the Hommel Test for Clinical Trial Applications , 2011, Journal of biopharmaceutical statistics.